StemCell Therapy

Los Angeles, CA (PRWEB) May 05, 2014

Tennis elbow is a common condition affecting 40-60 years aged adults. Though it is not a critical condition, it is potentially disabling in the sense that it restricts the certain activities of tennis players. MetroMD Institute of Regenerative Medicine, Los Angeles, offers an innovative treatment with PRP- Platelet Rich Plasma- a minimally invasive procedure. The therapy takes fewer months for rehabilitation and correct elbow injury in a way that traditional methods cannot do. Source: Dr. Alex Martin - MetroMD Institute of Regenerative Medicine, 7080 Hollywood Blvd, Los Angeles, California.

Tennis elbow is caused by repetitive strain to the tendon in the elbow. Consequently, due to the overuse and strain, elbows have damaged ligaments in the area. Scientifically, this condition is known as lateral epicondylitis. MetroMD, LA, treats vastitude of players with tennis elbow with a minimally invasive procedure with less time for rehabilitation. Dr. Alex Martin, Medical Doctor at the Institute, introduces the latest technologies in regenerative medicine - prolotherapy and platelet-rich plasma treatment (PRP) is one of them. The therapy involves the use of stem cells harvested from the patients bone marrow along with PRP and re-injecting the derived concentrated solution to the damaged soft tissue in the elbow for regeneration. Further, the stem cell specialist accurately places the cells to the troubled area. Once the cells are placed as the way they are required to, the healing process commences. Gradually, the sport players start to restore to full recovery. Patients become able to reuse their elbow and come back to normalcy to continue the sports for as long as they want.

The revolutionary stem cell option is a new attempt to cure the tennis elbow in players with PRP injections to better health. The best part of the treatment is it restores to full health without having the need to go for invasive procedure, unlike conventional surgical methods." says Alex Martin, Medical Doctor, MetroMD, Los Angeles. To know more about the regenerative medicine, please visit http://www.metromd.net.

About MetroMD

MetroMD is a Los Angeles based clinical institute and a leading provider of PRP, Stem Cell Therapy and numerous others. The institute treats the patients with latest technology to treat aging, improve sports performance, texture of hair, nail with HGH therapy. All the treatments are FDA approved and hence considered safe. The institute runs licensed Stem Cell Therapy clinic in Los Angeles. __title__ How to Repair Elbow Joints with PRP]

Here is the original post:
The New Cellular Medicine from MetroMD Stem Cell PRP Helps Tennis Elbow Sufferers, and Other Athletes to Recover ...

Stem Cells 101 and Beyond
Divya Mathur and Chris Lengner from Rudolf Jaenisch #39;s lab at the Whitehead Institute discuss the basics of stem cell research, as well as their latest findings.

By: Forum Network

Read the original here:
Stem Cells 101 and Beyond - Video

Stem Cells Transplantation Treatment By VLCC - Doctors Talk
Doctors Talk is an exclusive program by CVR Health TV in which a specialist will discuss about different health problems and suggest remedies. Today #39;s Doctor...

By: CVR Health TV

View original post here:
Stem Cells Transplantation Treatment By VLCC - Doctors Talk - Video

Dental Talk Show - Dental Stem Cells, Dental Show Preview Competition News
Host Nick Peters discusses Stem cell research and how the use of Stem Cells from Teeth are showing promising potential in the use of Stroke Therapy due to there likeness of Brain Neurons. #DentalNe...

By: NIck Peters

Read the original post:
Dental Talk Show - Dental Stem Cells, Dental Show Preview & Competition News - Video

Hip and knee arthritis 5 months after stem cell therapy by Dr Harry Adelson
Richard describes his outcome 5 months after stem cell therapy by Dr Harry Adelson for his hip and knee arthritis http://www.docereclinics.com.

By: Harry Adelson, N.D.

Go here to read the rest:
Hip and knee arthritis 5 months after stem cell therapy by Dr Harry Adelson - Video

Scottsdale, Arizona (PRWEB) May 05, 2014

Top Phoenix and Scottsdale foot and ankle doctors at Valley Foot Surgeons are now offering stem cell procedures for the nonoperative treatment of Achilles tendonitis and tears. The regenerative medicine procedures are typically able to provide exceptional pain relief while allowing patients the ability to avoid surgery. Call (480) 420-3499 for more information and scheduling about the foot and ankle stem cell procedures.

To date, the lead foot and ankle doctor at Valley Foot Surgeons, Dr. Richard Jacoby, has performed close to 100 regenerative medicine procedures. Typically, these are administered for a variety of conditions such as diabetic ulcers, foot and ankle arthritis, plantar fasciitis, and Achilles injuries.

Conditions with the Achilles tendon may include pain due to chronic tendonitis or tears from degeneration. This may occur during a sporting activity, traumatic event, or simply as part of an individual's tendon weakening after taking quinolone antibiotics.

The stem cell procedures are performed as an outpatient, with the injections consisting of amniotic derived stem cells. The material is harvested from consenting donors after scheduled c-section procedures, with no fetal tissue at all being used.

The material is exceptionally rich in stem cells, growth factors, hyaluronic acid, and more. This can dramatically improve pain relief and healing, which is very different from how steroid medications work.

All too often, traditional treatments for Achilles tendonitis and tears fail to provide relief. This may lead to potentially risky surgery, where complications may lead to continued disability.

With the stem cells for Achilles tears and tendonitis, patients go through an outpatient procedure that is low risk and offers the potential for avoiding the risks of surgery while speeding up recovery.

Dr. Jacoby at Valley Foot Surgeons has been a four time Phoenix Top Doc Winner and sees patients out of two offices in the Valley. For the top stem cell treatment for achilles conditions, diabetic wounds, foot and ankle arthritis and more, call (480) 420-3499.

Follow this link:
Valley Foot Surgeons Now Offering Stem Cell Procedures for Achilles Tendonitis and Tears for Pain Relief and Helping ...

Hematopoietic Stem Cells and Atherosclerosis
Distinguished Lecturer, Alan Tall, MD, FAHA, provides an overview of the presentation he was invited to give on his recent work on hematopoietic stem cells a...

By: AHAScienceNews

Link:
Hematopoietic Stem Cells and Atherosclerosis - Video

Human embryonic stem cells can become any cell in the body. AFP FILE PHOTO

MANILA, Philippines Health authorities warned the public anew on Saturday about health facilities and medical practitioners offering unauthorized stem cell therapy and products.

In an advisory, the Food and Drug Administration said that to date, not one stem cell or human cells, tissues, and cellular and tissue-based products (HCT/Ps) that applied for registration has been registered by the FDA for compassionate or clinical trial use, or general use.

The use of HCT/Ps without the authorization or permission by the FDA is considered illegal, it said, reminding hospitals and health facilities of the provisions of the FDA Act of 2009, which prohibits the manufacture, use, advertisement or sponsorship of unregistered health products.

This warning extends to all unlicensed practitioners from other countries and to tourists who visit the Philippines for leisure and medical needs, the advisory added.

According to FDA acting director general Kenneth Hartigan Go, the FDA recognizes only hematopoietic (pertaining to the formation and development of blood cells) stem cell transplantation, corneal resurfacing with limbal stem cells and skin regeneration with epidermal stem cells as generally accepted standards of health care procedures.

If health institutions are doing these three procedures, they can continue doing them because those are allowed. Go said, adding that the efficacy of the use of stem cells for the treatment of other diseases, such as diabetes, cancer and autism, among others, has yet to be proven.

Go noted that while many spa centers and salons are advertising stem cell therapy and products, none of them has the approval of the health agency.

As of now we have not accredited any health facility offering stem cell therapy yet, Go said.

Several facilities had applied for accreditation but Go said many of these were asked to correct their deficiencies.

See the original post here:
Public warned of fly-by-night stem cell procedures, products

Health authorities on Saturday reissued warnings against health facilities and medical practitioners offering stem-cell therapies or related products, which promise to cure a range of diseases, arrest the aging process or even increase libido.

In an advisory, the Food and Drug Administration stressed that to date not one stem cell or human cells, tissues, and cellular and tissue-based products (HCT/Ps) that applied for registration has been registered by the FDA for compassionate or clinical trial use or for general use.

The use of HCT/Ps without the authorization or permission by the FDA is considered illegal, it said. The agency warned hospitals and health facilities of the provisions of the FDA Act of 2009, which prohibits the manufacture, use, advertisement or sponsorship of unregistered health products.

This warning extends to all unlicensed practitioners from other countries and to tourists who visit the Philippines for leisure and medical needs.

According to FDA acting director general Kenneth Hartigan Go, the FDA recognizes only hematopoietic (pertaining to the formation and development of blood cells) stem-cell transplantation, corneal resurfacing with limbal stem cells and skin regeneration with epidermal stem cells as generally accepted standards of healthcare procedures.

If health institutions are doing these three procedures, they can continue because those are allowed, Go said.

But the efficacy of the use of stem cells for the treatment of other diseases, such as diabetes, cancer and autism, among others, have yet to be proven, he said.

Go noted that while many spa centers and salons are advertising stem-cell therapy treatment and products, none of them have secured the FDAs approval. As of now, we have not accredited any health facility offering stem-cell therapy yet.

Applicants with deficiencies

Read more:
FDA: No way spas can do stem-cell therapy

Four Ways Stem Cells Will Change the Face of Medicine
Stem cells are undifferentiated cells that can be transformed into specialized cells to repair and replenish human tissue. California #39;s stem cell agency is e...

By: MilkenInstitute

More:
Four Ways Stem Cells Will Change the Face of Medicine - Video

Pronounce Medical Words Autologous Expanded Mesenchymal Stem Cells OTI010
This video shows you how to say Autologous Expanded Mesenchymal Stem Cells OTI010. How would you pronounce Autologous Expanded Mesenchymal Stem Cells OTI010?

By: Medical 101

See more here:
Pronounce Medical Words Autologous Expanded Mesenchymal Stem Cells OTI010 - Video

Stem Cells Save the Hopes of a Florida High School Soccer Star
Stem Cells save the hopes of Florida high school soccer star Natasha Merangoli as Avascular Necrosis in her ankle nearly sidelines her for life. Her orthopedic surgeons told her to pick a...

By: Jason Pedley

Read this article:
Stem Cells Save the Hopes of a Florida High School Soccer Star - Video

April Flowers for redOrbit.com Your Universe Online

A new study, from the Stanford University School of Medicine and Montana State University, demonstrates that, when implanted into the reproductive system of a mouse model, stem cells created from adult, infertile men will yield primordial germ cells. Primordial germ cells normally become sperm cells.

The findings, published in Cell Reports, help to further our understanding of a genetic cause of male infertility and basic sperm biology. The research team says that their approach holds considerable potential for clinical applications.

All of the infertile male participants suffer from a genetic mutation that prevents their bodies from producing mature sperm. The study suggests that the men with this condition called azoospermia might have produced germ cells at some point in their early lives, but these cells were lost as the men matured to adulthood.

Our results are the first to offer an experimental model to study sperm development, said Renee Reijo Pera of the Institute for Stem Cell Biology & Regenerative Medicine and Montana State University. Therefore, there is potential for applications to cell-based therapies in the clinic, for example, for the generation of higher quality and numbers of sperm in a dish.

It might even be possible to transplant stem-cell-derived germ cells directly into the testes of men with problems producing sperm, she added. Considerable study to ensure safety and practicality is needed, however, before reaching that point.

Infertility is a fairly common problem, affecting between 10 and 15 percent of couples in the US. The researchers say that many men are affected by genetic causes of infertility, most commonly due to the spontaneous loss of key genes on the Y sex chromosome. Until now, the causes of infertility at the molecular level have not been clear.

The fact that the research team was able to create primordial germ cells from the infertile men is very promising, but they note that these stem cells created far fewer of these sperm progenitors than the stem cells of men without the genetic mutations. They are sure, however, that this research provides a much needed model to study the earliest steps of human reproduction.

We saw better germ-cell differentiation in this transplantation model than weve ever seen, said Reijo Pera, former director of Stanfords Center for Human Embryonic Stem Cell Research and Education. We were amazed by the efficiency. Our dream is to use this model to make a genetic map of human germ-cell differentiation, including some of the very earliest stages.

Humans share many cellular and physiological processes with common laboratory animals such as mice or fruit flies. In reproduction, however, there are significant variances, making it challenging to recreate the human reproductive processes in a laboratory setting. In addition, many crucial steps, such as the development and migration of primordial germ cells to the gonads,occur in the relatively short first days or weeks after conception.

Continue reading here:
Stem Cells Of Infertile Men Used To Create Preliminary Sperm Cells

The future of the University of Minnesotas regenerative medicine research program is looking brighter than ever.

State and federal leaders in the past have denied funding for the Universitys Office of Regenerative Medicine, which includes the Stem Cell Institute, because some had ethical disagreements with stem cell research.

But this legislative session, with a DFL majority and an overall shift in public opinion, researchers and legislators are confident funding will come through this year.

The current House bill sets aside $450,000 for the Office of Regenerative Medicine, while the Senate version outlines a $5 million increase each year from 2015-17. The bills texts dont specify how funds should be used and how they would be divided between the University and the Mayo Clinic, its research partner.

The Senates bill mandates that anadvisory task force comprised of members from the University, the Mayo Clinic and private industry, as well as two other regenerative medicine experts, recommend how to spend the state funding.

Dayton didnt include funds for the research in his original budget proposal this year, but Sen. Terri Bonoff, DFL-Minnetonka, said there seems to be a general consensus among legislators to work together and decide on a funding amount.

I have not heard many naysayers, she said.

Changing perceptions

The state plays a major role in moving the institutes research forward.

These days, legislators are more open to it than they were in the past, said Dr. Andre Terzic, director of the Mayo Clinic Center for Regenerative Medicine.

Continue reading here:
Legislature could boost U stem cell research

(PRWEB) May 02, 2014

The report Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW).

Browse 57 market data tables 32 figures spread through 196 Slides and in-depth TOC on Stem Cell Therapy Market http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html

Early buyers will receive 10% customization on report.

This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.

Download Free PDF Download @ http://www.marketsandmarkets.com/pdfdownload.asp?id=48

The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. In addition, based on the therapeutic applications, the global stem cell therapy market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=48

A number of factors such as the increasing funding from various government and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are stimulating the research activities for stem cell therapies. Developing markets, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs), and evolution of new stem cell therapies represent high growth opportunities for market players.

In 2015, North America will hold the largest share of the global stem cell therapy market. This large share is primarily attributed to the extensive government funding and increasing fast-track approval for stem cell therapeutics by the FDA. Moreover, development of advanced genomic methods for stem cell analysis and high number of ongoing research activities are further fueling the growth of the stem cell therapy market in North America. However, the Asia-Pacific stem cell therapy market is expected to grow at the highest CAGR in the forecast period, owing to factors such as increasing regulatory support through favorable government policies, strong product pipelines, and increasing licensing activities in this region.

Original post:
Stem Cell Therapy Market (Autologous & Allogeneic) Worth $330 Million in 2020 - New Report by MarketsandMarkets

A new review of previous scientific studies has concluded that stem cell therapy may help reduce the number of deaths in heart patients.

The Cochrane Heart Review Group analyzed data from studies involving just over 1,200 patients in 23 randomized, controlled trials.

The group's report on the potential benefits of stem cell heart repair was published online on April 29 in The Cochrane Library. The Cochrane Reviews are systematic assessments of evidence-based research into human health care and health policy.

There were fewer deaths among heart patients receiving stem cell therapy in addition to standard treatment, compared to patients who were treated with traditional therapies alone or with a placebo. Stem cells are primitive master cells that, under the right conditions, can turn into any cell in the body.

The therapy also reduced the chances that patients, with improved heart function, had to be readmitted to the hospital.

The review noted that stem cell therapy could possibly reduce the number of deaths after one year, but the results of larger clinical trials are needed.

The stem cells are taken from a patients own bone marrow and injected into the hearts of patients with ischemic heart disease and congestive heart failure, repairing damaged cardiac tissue.

Dr. Enca Martin-Rendon, author of the review in Britain, said, This is encouraging evidence that stem cell therapy has benefits for heart disease patients. However, Martin-Rendon noted it is difficult to come to any concrete conclusions until larger clinical trials are carried out.

See the original post:
Stem Therapy May Improve Survival of Heart Patients

New York, NY (PRWEB) May 02, 2014

Stem Cell Institute is releasing additional tickets for its Adult Stem Cell Therapy Clinical Trials seminar on Saturday, May 17, 2014 in New York City at the New York Hilton Midtown from 1:00 pm to 4:00 pm.

After booking its original meeting room beyond capacity, the Stem Cell Institute has reserved a larger room to accommodate additional attendees. The seminar will now take place in the Beekman Room, 2nd Floor, East Corridor of the New York Hilton Midtown.

Those interested in attending are encouraged to register promptly. Only 75 additional seats are available.

Speakers include:

Neil Riordan PhD Clinical Trials: Umbilical Cord Mesenchymal Stem Cell Therapy for Autism and Spinal Cord Injury

Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD Stem Cell Therapy for Autoimmune Disease: MS, Rheumatoid Arthritis and Lupus

Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Special guest speaker:

Here is the original post:
Additional Tickets Released for Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in New ...

MS Life 2014 - Research Talks - Stem Cells

By: MS Society

Here is the original post:
MS Life 2014 - Research Talks - Stem Cells - Video

Are Stem Cells The Key To Anti-Aging? | Larry King Now - Ora TV
Are Stem Cells The Key To Anti-Aging? | Larry King Now - Ora TV SUBSCRIBE to Larry King #39;s YouTube Channel:http://bit.ly/131HuYM Reality TV stars Janice Dicki...

By: Larry King

More here:
Are Stem Cells The Key To Anti-Aging? | Larry King Now - Ora TV - Video

Dr. Max Gomez: Scientists Use Stem Cells To Grow Human Muscle
As CBS 2 #39;s Dr. Max Gomez explained, the breakthrough could restore function to thousands of seriously injured patients.

By: CBS New York

Read the original post:
Dr. Max Gomez: Scientists Use Stem Cells To Grow Human Muscle - Video